nepafenac 3 MG/ML Ophthalmic Suspension

RxCUI: 1362132
RxNorm name: nepafenac 3 MG/ML Ophthalmic Suspension
Display name: nepafenac 3 MG/ML Ophthalmic Suspension
Full name: nepafenac 3 MG/ML Ophthalmic Suspension
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ILEVRO	NEPAFENAC	Novartis Pharmaceuticals Corporation	f089b583-0310-4ca8-8d41-52b06b08d1ed	2026-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 1362132
ILEVRO	NEPAFENAC	Harrow Eye, LLC	10f411d3-a81e-074a-e063-6294a90ab547	2026-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 1362132

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
10f411d3-a81e-074a-e063-6294a90ab547	nepafenac 0.3 % Ophthalmic Suspension [PSN] · nepafenac 3 MG/ML Ophthalmic Suspension [SCD] · nepafenac 0.3 % Ophthalmic Suspension [SY]	3	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401
f089b583-0310-4ca8-8d41-52b06b08d1ed	nepafenac 0.3 % Ophthalmic Suspension [PSN] · nepafenac 3 MG/ML Ophthalmic Suspension [SCD] · nepafenac 0.3 % Ophthalmic Suspension [SY]	3	5	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005	20260401